Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF-α signaling may thereby play an important role in producing depressive symptoms, consistent with prior work linking sTNF-RII with cognitive complaints [74] and fatigue [46, 75] in women with breast cancer.”
From Moderators of inflammation-related depression: a prospective study of breast cancer survivors (2021) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134
Self-citation(1991) · Sleep · doi:10.1093/sleep/14.4.331 · Cited by 874 · cited 1×
“Subjective sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI), a 19-item questionnaire with high internal consistency, test–retest reliability, and diagnostic validity with insomnia diagnosis (Buysse et al., 1991).”
MethodHann (1998) · Quality of Life Research · doi:10.1023/a:1008842517972 · Cited by 500
Neural sensitivity to social rejection is associated with inflammatory responses to social stress
Slavich, G. M., Way, B. M., Eisenberger, N. I., & Taylor, S. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009164107 · Cited by 418 · cited 1×
“For example, sTNF-RII, but not IL-6, was correlated with stress-induced changes in the CNS (Slavich et al., 2010), and sTNF-RII predicted coronary heart disease independent of CRP (Shai et al.”
BackgroundHan, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008) · Journal of Biology · doi:10.1186/jbiol69 · Cited by 316
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer
Bower, J. E., Ganz, P. A., Tao, M. L., Hu, W., Belin, T. R., Sepah, S., Cole, S., & Aziz, N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2584 · Cited by 315
Self-citationIdentifying clinically meaningful fatigue with the fatigue symptom inventory
Donovan, K. A., Jacobsen, P. B., Small, B. J., Munster, P. N., & Andrykowski, M. A. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.11.013 · Cited by 144 · cited 1×
“Fatigue was assessed using the Fatigue Symptom Inventory (FSI), a valid and reliable 14-item measure specifically designed to assess fatigue in cancer populations (Hann et al., 1998; Donovan et al., 2008; Donovan and Jacobsen, 2010).”
MethodTulsky, D. S., & Price, L. R. (2003) · Psychological Assessment · doi:10.1037/1040-3590.15.2.149 · Cited by 131 · cited 1×
“These scores were then used to create NP test domains based upon prior factor analytic studies of larger NP data sets and groupings used in other studies with this population (Tulsky and Price, 2003).”
MethodThe Fatigue Symptom Inventory: a systematic review of its psychometric properties
Donovan, K. A., & Jacobsen, P. B. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0989-4 · Cited by 94
Research works printed but not linked: 50
- Ahles, 2002, Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma, J. Clin. Oncol., 20, 485, 10.1200/JCO.2002.20.2.485 · DOI · Paper page
- Ahles, 2008, Cognitive function in breast cancer patients prior to adjuvant treatment, Breast Cancer Res. Treat., 110, 143, 10.1007/s10549-007-9686-5 · DOI · Paper page
- Ahles, 2007, Candidate mechanisms for chemotherapy-induced cognitive changes, Nat. Rev. Cancer, 7, 192, 10.1038/nrc2073 · DOI · Paper page
- Ahles, 2010, Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve, J. Clin. Oncol., 28, 4434, 10.1200/JCO.2009.27.0827 · DOI · Paper page
- Alexander, 2009, A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome, Eur. J. Cancer, 45, 384, 10.1016/j.ejca.2008.09.010 · DOI · Paper page
- Bower, 2002, Fatigue and proinflammatory cytokine activity in breast cancer survivors, Psychosom. Med., 64, 604, 10.1097/00006842-200207000-00010 · DOI · Paper page
- Bower, 2007, Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids, Brain Behav. Immun., 21, 251, 10.1016/j.bbi.2006.08.001 · DOI · Paper page
- Bower, 2007, Cancer-related fatigue: links with inflammation in cancer patients and survivors, Brain Behav. Immun., 21, 863, 10.1016/j.bbi.2007.03.013 · DOI · Paper page
- Bower, 2008, Behavioral symptoms in patients with breast cancer and survivors, J. Clin. Oncol., 26, 768, 10.1200/JCO.2007.14.3248 · DOI · Paper page
- Bower, 2011, Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?, J. Clin. Oncol., 29, 3517, 10.1200/JCO.2011.36.1154 · DOI · Paper page
- Butler, 1994, Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer, J. Clin. Oncol., 12, 2621, 10.1200/JCO.1994.12.12.2621 · DOI · Paper page
- Capuron, 2004, Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy, Brain Behav. Immun., 18, 205, 10.1016/j.bbi.2003.11.004 · DOI · Paper page
- Castellon, 2004, Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen, J. Clin. Exp. Neuropsychol., 26, 955, 10.1080/13803390490510905 · DOI · Paper page
- Collado-Hidalgo, 2006, Inflammatory biomarkers for persistent fatigue in breast cancer survivors, Clin. Cancer Res., 12, 2759, 10.1158/1078-0432.CCR-05-2398 · DOI · Paper page
- Collado-Hidalgo, 2008, Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings, Brain Behav. Immun., 22, 1197, 10.1016/j.bbi.2008.05.009 · DOI
- Deprez, 2012, Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning, J. Clin. Oncol., 30, 274, 10.1200/JCO.2011.36.8571 · DOI · Paper page
- Donovan, 2004, Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer, J. Pain Symptom Manage., 28, 373, 10.1016/j.jpainsymman.2004.01.012 · DOI · Paper page
- Ferguson, 2007, Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy, J. Clin. Oncol., 25, 3866, 10.1200/JCO.2007.10.8639 · DOI · Paper page
- Friston, K.J., Ashburner, J.T., Kiebel, S.J., Nichols, T.E., Penny, W.D., 2007. Statistical Parametric Mapping: The Analysis of Functional Brain Images. Academic Press, Burlington, MA.
- Ganz, P.A., Castellon, S.A., Silverman, D.H.S., Kwan, L., Bower, J.E., Irwin, M.R., Cole, S.W., 2011a. Does circulating tumor necrosis factor (TNF) play a role in post-chemotherapy cerebral dysfunction in breast cancer survivors (BCS)? In: Abstract presented at Annual Meeting of the American Society of Clinical Oncology, Chicago, June 3, 2011. · doi:10.1200/jco.2011.29.15_suppl.9008
- Ganz, 2011, Physical and psychosocial recovery in the year after primary treatment of breast cancer, J. Clin. Oncol., 29, 1101, 10.1200/JCO.2010.28.8043 · DOI · Paper page
- Ganz, P.A., Kwan, L., Castellon, S.A., Bower, J.E., Silverman, D.H.S., Irwin, M.R., Cole, S.W., 2012. Cognitive complaints in breast cancer patients: associations with therapy and cytokine markers. In: Abstract presented at the International Cognition and Cancer Task Force Conference Meeting, Paris, March 16, 2012.
- Jenkins, 2006, A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer, Br. J. Cancer, 94, 828, 10.1038/sj.bjc.6603029 · DOI · Paper page
- Joshi, 2010, Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain, Neuroscience, 166, 796, 10.1016/j.neuroscience.2010.01.021 · DOI
- Joshi, 2005, Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain, Free Radic. Res., 39, 1147, 10.1080/10715760500143478 · DOI · Paper page
- Kesler, 2011, Prefrontal cortex and executive function impairments in primary breast cancer, Arch. Neurol., 68, 1447, 10.1001/archneurol.2011.245 · DOI · Paper page
- McDonald, 2010, Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study, Breast Cancer Res. Treat., 123, 819, 10.1007/s10549-010-1088-4 · DOI · Paper page
- Meyers, 2000, Neurocognitive dysfunction in cancer patients, Oncology (Huntingt), 14, 75
- Meyers, C.A., 2008. How chemotherapy damages the central nervous system. J. Biol. 7 (4), 11 (Epub April 22). · DOI
- Miller, 2008, Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer, J. Clin. Oncol., 26, 971, 10.1200/JCO.2007.10.7805 · DOI · Paper page
- Orre, 2009, Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue, Brain Behav. Immun., 23, 868, 10.1016/j.bbi.2009.04.003 · DOI
- Phillips, 2011, Cognitive functioning after cancer treatment, Cancer, 118, 1925, 10.1002/cncr.26432 · DOI
- Rasgon, 2005, Estrogen use and brain metabolic change in postmenopausal women, Neurobiol. Aging, 26, 229, 10.1016/j.neurobiolaging.2004.03.003 · DOI
- Saykin, 2006, Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI, Neurology, 67, 834, 10.1212/01.wnl.0000234032.77541.a2 · DOI · Paper page
- Schagen, 2006, Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients, J. Natl. Cancer Inst., 98, 1742, 10.1093/jnci/djj470 · DOI · Paper page
- Schagen, 1999, Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma, Cancer, 85, 640, 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G · DOI · Paper page
- Shai, 2005, A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes, Diabetes Care, 28, 1376, 10.2337/diacare.28.6.1376 · DOI
- Silverman, 2007, Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy, Breast Cancer Res. Treat., 103, 303, 10.1007/s10549-006-9380-z · DOI · Paper page
- Squire, 1979, Memory complaints after electroconvulsive therapy: assessment with a new self-rating instrument, Biol. Psychiatry, 14, 791
- Stein, 2000, Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer, J. Pain Symptom Manage., 19, 436, 10.1016/S0885-3924(00)00142-1 · DOI
- Syrjala, 2011, Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years, J. Clin. Oncol., 29, 2397, 10.1200/JCO.2010.33.9119 · DOI
- Talairach, J., Tournoux, P., 1988. Co-planar stereotaxic atlas of the human brain. 3-Dimensional Proportional System: An Approach to Cerebral Imaging. Thieme, New York.
- Tannock, 2004, Cognitive impairment associated with chemotherapy for cancer: report of a workshop, J. Clin. Oncol., 22, 2233, 10.1200/JCO.2004.08.094 · DOI · Paper page
- van Dam, F.S., Schagen, S.B., Muller, M.J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M.E., Rodenhuis, S., 1998. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J. Natl. Cancer Inst. 90, 210–218. · DOI · Paper page
- Vardy, 2008, Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop, Ann. Oncol., 19, 623, 10.1093/annonc/mdm500 · DOI · Paper page
- Wang, 2010, Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy, Brain Behav. Immun., 24, 968, 10.1016/j.bbi.2010.03.009 · DOI · Paper page
- Wang, 2012, Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy, Brain Behav. Immun., 26, 699, 10.1016/j.bbi.2011.12.007 · DOI
- Wefel, 2004, The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial, Cancer, 100, 2292, 10.1002/cncr.20272 · DOI · Paper page
- Wefel, 2008, Neuropsychological sequelae of non-central nervous system cancer and cancer therapy, Neuropsychol. Rev., 18, 121, 10.1007/s11065-008-9058-x · DOI
- Wefel, 2010, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 116, 3348, 10.1002/cncr.25098 · DOI · Paper page
Cited by
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Cognitive Effects of Cancer and Cancer Treatments
Ahles, T. A., & Root, J. C. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084903 · Cited by 367
Skvarc, D. R., Berk, M., Byrne, L. K., Dean, O. M., Dodd, S., Lewis, M., Marriott, A., Moore, E. M., Morris, G., Page, R. S., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.011 · Cited by 312
Clark, I. A., & Vissel, B. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0708-2 · Cited by 123
Metadata
- Authors
- Ganz, P. A., Bower, J. E., Kwan, L., Castellon, S. A., Silverman, D. H. S., Geist, C., Breen, E. C., Irwin, M. R., & Cole, S. W.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 30
- Pages
- S99-S108
- ISSN
- 0889-1591
- Cited by
- 140
- References
- 10
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.